The cellular uptake of pharmaceutical drugs is mainly carrier-mediated and is thus an issue not so much of biophysics but of systems biology
暂无分享,去创建一个
[1] E. Overton. Studien über die Narkose : zugleich ein Beitrag zur allgemeinen Pharmakologie , 1901 .
[2] Bertrand Russell. Am I an atheist or an agnostic , 1950 .
[3] D. O. Rudin,et al. Reconstitution of Cell Membrane Structure in vitro and its Transformation into an Excitable System , 1962, Nature.
[4] I. Ueda. Effects of Diethyl Ether and Halothane on Firefly Luciferin Bioluminescence , 1965, Anesthesiology.
[5] W. R. Lieb,et al. Biological Membranes behave as Non-porous Polymeric Sheets with Respect to the Diffusion of Non-electrolytes , 1969, Nature.
[6] A. Parsegian,et al. Energy of an Ion crossing a Low Dielectric Membrane: Solutions to Four Relevant Electrostatic Problems , 1969, Nature.
[7] P. Seeman,et al. The membrane actions of anesthetics and tranquilizers. , 1972, Pharmacological reviews.
[8] S. Singer,et al. The fluid mosaic model of the structure of cell membranes. , 1972, Science.
[9] F. Johnson. The Bimolecular Lipid Membrane: A System , 1973 .
[10] H. Ti Tien,et al. Bilayer lipid membranes (BLM) : theory and practice , 1974 .
[11] P. Barts,et al. Uptake of the lipophilic cation dibenzyldimethylammonium into Saccharomyces cerevisiae. Interaction with the thiamine transport system. , 1980, Biochimica et biophysica acta.
[12] N. P. Franks,et al. Do general anaesthetics act by competitive binding to specific receptors? , 1984, Nature.
[13] R. Dickinson,et al. Can the stereoselective effects of the anesthetic isoflurane be accounted for by lipid solubility? , 1994, Biophysical journal.
[14] D B Kell,et al. Solvent selection for whole cell biotransformations in organic media. , 1995, Critical reviews in biotechnology.
[15] A. Blume,et al. A comparative study of diffusive and osmotic water permeation across bilayers composed of phospholipids with different head groups and fatty acyl chains. , 1995, Biophysical journal.
[16] P. Hajduk,et al. Discovering High-Affinity Ligands for Proteins: SAR by NMR , 1996, Science.
[17] J. Weaver,et al. Theory of electroporation: A review , 1996 .
[18] Zbigniew Michalewicz,et al. Handbook of Evolutionary Computation , 1997 .
[19] R. Harris,et al. Sites of alcohol and volatile anaesthetic action on GABAA and glycine receptors , 1997, Nature.
[20] John M. Barnard,et al. Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..
[21] Douglas B. Kell,et al. Non-linear optimization of biochemical pathways: applications to metabolic engineering and parameter estimation , 1998, Bioinform..
[22] P. Brick,et al. Structural basis for the inhibition of firefly luciferase by a general anesthetic. , 1998, Biophysical journal.
[23] N R Smalheiser,et al. Using ARROWSMITH: a computer-assisted approach to formulating and assessing scientific hypotheses. , 1998, Computer methods and programs in biomedicine.
[24] Riccardo Poli,et al. New ideas in optimization , 1999 .
[25] Michael D. Gordon,et al. Literature-based discovery by lexical statistics , 1999 .
[26] F. Bordi. Ion transport in lipid bilayer membranes through aqueous pores , 1999 .
[27] C. Lipinski. Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.
[28] R. Dickinson,et al. Stereoselective loss of righting reflex in rats by isoflurane. , 2000, Anesthesiology.
[29] A century of thinking about cell membranes. , 2000, Annual review of physiology.
[30] Petra Schneider,et al. De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks , 2000, J. Comput. Aided Mol. Des..
[31] P. De Weer,et al. A Century of Thinking About Cell Membranes , 2000 .
[32] K. Wafford,et al. Mechanism of action of general anaesthetics--new information from molecular pharmacology. , 2001, Current opinion in pharmacology.
[33] D B Kell,et al. Genomic computing. Explanatory analysis of plant expression profiling data using machine learning. , 2001, Plant physiology.
[34] Han van de Waterbeemd,et al. Property-Based Design: Optimization of Drug Absorption and Pharmacokinetics , 2001 .
[35] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[36] RONALD N. KOSTOFF. Overcoming Specialization , 2002 .
[37] K. Miller,et al. The nature of sites of general anaesthetic action. , 2002, British journal of anaesthesia.
[38] H. Jhoti,et al. Structure-based screening of low-affinity compounds. , 2002, Drug discovery today.
[39] T. Buzan. How to Mind Map , 2002 .
[40] Ajay. Predicting drug-likeness: why and how? , 2002, Current topics in medicinal chemistry.
[41] B. Urban. Current assessment of targets and theories of anaesthesia. , 2002, British journal of anaesthesia.
[42] B. Antkowiak,et al. General anesthetic actions in vivo strongly attenuated by a point mutation in the GABAA receptor β3 subunit , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[43] M. Congreve,et al. A 'rule of three' for fragment-based lead discovery? , 2003, Drug discovery today.
[44] R. Guidelli. Planar Lipid Bilayers (BLMs) and Their Applications: H.T. Tien, A. Ottova-Leitmannova (Eds.), Elsevier, Amsterdam, 2003 , 2003 .
[45] K. Miller,et al. Mechanisms of actions of inhaled anesthetics. , 2003, The New England journal of medicine.
[46] Hiroaki Kitano,et al. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models , 2003, Bioinform..
[47] Carmen G. Moles,et al. Parameter estimation in biochemical pathways: a comparison of global optimization methods. , 2003, Genome research.
[48] Joanna Owens,et al. Chris Lipinski discusses life and chemistry after the Rule of Five. , 2003 .
[49] W. Sadee,et al. Intestinal membrane transport of drugs and nutrients: genomics of membrane transporters using expression microarrays. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[50] Nigel W. Hardy,et al. A proposed framework for the description of plant metabolomics experiments and their results , 2004, Nature Biotechnology.
[51] B. Antkowiak,et al. Molecular and neuronal substrates for general anaesthetics , 2004, Nature Reviews Neuroscience.
[52] N. Franks,et al. The TREK K2P channels and their role in general anaesthesia and neuroprotection. , 2004, Trends in pharmacological sciences.
[53] M. Congreve,et al. Fragment-based lead discovery , 2004, Nature Reviews Drug Discovery.
[54] Akira Tsuji,et al. Transporter-mediated drug delivery: recent progress and experimental approaches. , 2004, Drug discovery today.
[55] Siewert J Marrink,et al. Molecular dynamics simulations of hydrophilic pores in lipid bilayers. , 2004, Biophysical journal.
[56] Erik M. van Mulligen,et al. Constructing an associative concept space for literature-based discovery , 2004, J. Assoc. Inf. Sci. Technol..
[57] Leslie Z. Benet,et al. Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System , 2004, Pharmaceutical Research.
[58] Daniel A Erlanson,et al. Making drugs on proteins: site-directed ligand discovery for fragment-based lead assembly. , 2004, Current opinion in chemical biology.
[59] D. Kell,et al. Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era. , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.
[60] J. Crison,et al. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.
[61] Daniel A. Erlanson,et al. Fragment‐Based Drug Discovery. , 2004 .
[62] Tudor I. Oprea,et al. Pursuing the leadlikeness concept in pharmaceutical research. , 2004, Current opinion in chemical biology.
[63] Anthony G Lee,et al. How lipids affect the activities of integral membrane proteins. , 2004, Biochimica et biophysica acta.
[64] Jürgen Bajorath,et al. Chemoinformatics : concepts, methods, and tools for drug discovery , 2004 .
[65] M. Lazdunski,et al. TREK‐1, a K+ channel involved in neuroprotection and general anesthesia , 2004, The EMBO journal.
[66] I. Kola,et al. Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.
[67] Christopher W Murray,et al. Fragment-based lead discovery using X-ray crystallography. , 2005, Journal of medicinal chemistry.
[68] Hans Lennernäs,et al. The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension , 2005, The Journal of pharmacy and pharmacology.
[69] Y. Sai,et al. Biochemical and molecular pharmacological aspects of transporters as determinants of drug disposition. , 2005, Drug metabolism and pharmacokinetics.
[70] Christian Blaschke,et al. Text Mining for Metabolic Pathways, Signaling Cascades, and Protein Networks , 2005, Science's STKE.
[71] B. Orser,et al. Emerging molecular mechanisms of general anesthetic action. , 2005, Trends in pharmacological sciences.
[72] Nigel W. Hardy,et al. MeMo: a hybrid SQL/XML approach to metabolomic data management for functional genomics , 2006, BMC Bioinformatics.
[73] Barend Mons,et al. Online tools to support literature-based discovery in the life sciences , 2005, Briefings Bioinform..
[74] Hugh D. Spence,et al. Minimum information requested in the annotation of biochemical models (MIRIAM) , 2005, Nature Biotechnology.
[75] S. Ananiadou,et al. Introduction to Text Mining for Biology and Biomedicine , 2006 .
[76] P. Mura,et al. Development and evaluation of an in vitro method for prediction of human drug absorption II. Demonstration of the method suitability. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[77] Bradley D Anderson,et al. Liposomal drug transport: a molecular perspective from molecular dynamics simulations in lipid bilayers. , 2006, Advanced drug delivery reviews.
[78] J. Sear,et al. Determinants of Volatile General Anesthetic Potency: A Preliminary Three-Dimensional Pharmacophore for Halogenated Anesthetics , 2006, Anesthesia and analgesia.
[79] P. Bork,et al. Literature mining for the biologist: from information retrieval to biological discovery , 2006, Nature Reviews Genetics.
[80] R. Olsen,et al. Low-dose alcohol actions on alpha4beta3delta GABAA receptors are reversed by the behavioral alcohol antagonist Ro15-4513. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[81] N. Franks,et al. Molecular targets underlying general anaesthesia , 2006, British journal of pharmacology.
[82] Sophia Ananiadou,et al. Text mining and its potential applications in systems biology. , 2006, Trends in biotechnology.
[83] P. Hajduk. Fragment-based drug design: how big is too big? , 2006, Journal of medicinal chemistry.
[84] D Peter Tieleman,et al. Lipids out of equilibrium: energetics of desorption and pore mediated flip-flop. , 2006, Journal of the American Chemical Society.
[85] Mudita Singhal,et al. COPASI - a COmplex PAthway SImulator , 2006, Bioinform..
[86] D. Kell. Systems biology, metabolic modelling and metabolomics in drug discovery and development. , 2006, Drug discovery today.
[87] B. Antkowiak,et al. Anaesthetic drugs: linking molecular actions to clinical effects. , 2006, Current pharmaceutical design.
[88] Sophia Hober,et al. A human protein atlas based on antibody proteomics. , 2006, Current opinion in molecular therapeutics.
[89] Maria Rodriguez-Fernandez,et al. A hybrid approach for efficient and robust parameter estimation in biochemical pathways. , 2006, Bio Systems.
[90] B. Fan,et al. Molecular similarity and diversity in chemoinformatics: From theory to applications , 2006, Molecular Diversity.
[91] Andrew R Leach,et al. Fragment screening: an introduction. , 2006, Molecular bioSystems.
[92] B. Palsson. Systems Biology: Properties of Reconstructed Networks , 2006 .
[93] M. Bleckwenn,et al. Interactions of anesthetics with their targets: non-specific, specific or both? , 2006, Pharmacology & therapeutics.
[94] Wanda Pratt,et al. Using statistical and knowledge-based approaches for literature-based discovery , 2006, J. Biomed. Informatics.
[95] D. Kell. Metabolomics, modelling and machine learning in systems biology – towards an understanding of the languages of cells , 2006, The FEBS journal.
[96] Neil R. Smalheiser,et al. Ranking indirect connections in literature-based discovery: The role of medical subject headings , 2006, J. Assoc. Inf. Sci. Technol..
[97] Roderick E Hubbard,et al. Informatics and modeling challenges in fragment-based drug discovery. , 2007, Current opinion in drug discovery & development.
[98] Chris Abell,et al. Fragment-based approaches to enzyme inhibition. , 2007, Current opinion in biotechnology.
[99] Douglas B Kell,et al. Metabolomic biomarkers: search, discovery and validation , 2007, Expert review of molecular diagnostics.
[100] Jan Schultz,et al. Integration of fragment screening and library design. , 2007, Drug discovery today.
[101] Li Di,et al. PAMPA--critical factors for better predictions of absorption. , 2007, Journal of pharmaceutical sciences.
[102] I. Vattulainen,et al. Molecular mechanism for lipid flip-flops. , 2007, The journal of physical chemistry. B.
[103] Roderick E Hubbard,et al. The SeeDs approach: integrating fragments into drug discovery. , 2007, Current topics in medicinal chemistry.
[104] P. Hajduk,et al. A decade of fragment-based drug design: strategic advances and lessons learned , 2007, Nature Reviews Drug Discovery.
[105] E. Bertaccini,et al. The Common Chemical Motifs Within Anesthetic Binding Sites , 2007, Anesthesia and analgesia.
[106] A. A. Gurtovenko,et al. Ion transport through chemically induced pores in protein-free phospholipid membranes. , 2007, The journal of physical chemistry. B.
[107] Jürgen Bajorath,et al. Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches. , 2007, Drug discovery today.
[108] P. Leeson,et al. The influence of drug-like concepts on decision-making in medicinal chemistry , 2007, Nature Reviews Drug Discovery.
[109] H. Jhoti,et al. Fragment-based drug discovery using rational design. , 2007, Ernst Schering Foundation symposium proceedings.
[110] Leann Nguyen,et al. Is PAMPA a useful tool for discovery? , 2007, Journal of pharmaceutical sciences.
[111] P Chiba,et al. Future directions for drug transporter modelling , 2007, Xenobiotica; the fate of foreign compounds in biological systems.
[112] Ronald N. Kostoff,et al. Literature-Related Discovery (LRD) , 2007 .
[113] O. Demin,et al. The Edinburgh human metabolic network reconstruction and its functional analysis , 2007, Molecular systems biology.
[114] K. Kremer,et al. Aggregation and vesiculation of membrane proteins by curvature-mediated interactions , 2007, Nature.
[115] Ken Solt,et al. Correlating the clinical actions and molecular mechanisms of general anesthetics , 2007, Current opinion in anaesthesiology.
[116] Douglas B Kell,et al. The virtual human: Towards a global systems biology of multiscale, distributed biochemical network models , 2007, IUBMB life.
[117] Monica L. Mo,et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.
[118] Neil R. Smalheiser,et al. A Quantitative Model for Linking Two Disparate Sets of Articles in Medline , 2022 .
[119] D. Broomhead,et al. Something from nothing − bridging the gap between constraint‐based and kinetic modelling , 2007, The FEBS journal.
[120] Alan E Mark,et al. Ion transport across transmembrane pores. , 2007, Biophysical journal.
[121] Hod Lipson,et al. Automated reverse engineering of nonlinear dynamical systems , 2007, Proceedings of the National Academy of Sciences.
[122] Richard Morphy,et al. Fragments, network biology and designing multiple ligands. , 2007, Drug discovery today.
[123] Pei Tang,et al. Dynamics of firefly luciferase inhibition by general anesthetics: Gaussian and anisotropic network analyses. , 2007, Biophysical journal.
[124] N. Blomberg,et al. An integrated approach to fragment-based lead generation: philosophy, strategy and case studies from AstraZeneca's drug discovery programmes. , 2007, Current topics in medicinal chemistry.
[125] Glyn Williams,et al. Fragment-based screening using X-ray crystallography and NMR spectroscopy. , 2007, Current opinion in chemical biology.
[126] Alexander A Alex,et al. Fragment-based drug discovery: what has it achieved so far? , 2007, Current topics in medicinal chemistry.
[127] Roderick E. Hubbard,et al. Diffraction Structural Biology Synchrotron Radiation Fragment Approaches in Structure-based Drug Discovery , 2007 .
[128] N. Franks. General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal , 2008, Nature Reviews Neuroscience.
[129] Ronald N. Kostoff,et al. Literature-related discovery (LRD): Methodology , 2008 .
[130] Douglas B Kell,et al. Proximate parameter tuning for biochemical networks with uncertain kinetic parameters. , 2008, Molecular bioSystems.
[131] C. Oppenheim,et al. The Access/Impact Problem and the Green and Gold Roads to Open Access: An Update , 2008 .
[132] Markus J. Herrgård,et al. A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology , 2008, Nature Biotechnology.
[133] Ferdinando Palmieri,et al. Diseases caused by defects of mitochondrial carriers: a review. , 2008, Biochimica et biophysica acta.
[134] David W. Deamer,et al. Origins of life: How leaky were primitive cells? , 2008, Nature.
[135] D. Kell,et al. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? , 2008, Nature Reviews Drug Discovery.
[136] Qing Yan,et al. Human membrane transporter database: A web-accessible relational database for drug transport studies and pharmacogenomics , 2000, AAPS PharmSci.
[137] Mark Whittaker,et al. Fragment-based activity space: smaller is better. , 2008, Current opinion in chemical biology.
[138] MB Kelz,et al. From Anesthetic Mechanisms Research to Drug Discovery , 2008, Clinical pharmacology and therapeutics.
[139] E. Lundberg,et al. Toward a Confocal Subcellular Atlas of the Human Proteome*S , 2008, Molecular & Cellular Proteomics.
[140] Magnus Rattray,et al. Bayesian inference of the sites of perturbations in metabolic pathways via Markov chain Monte Carlo , 2008, Bioinform..
[141] Pedro Mendes,et al. The markup is the model: reasoning about systems biology models in the Semantic Web era. , 2008, Journal of theoretical biology.
[142] Douglas B. Kell,et al. Automated manipulation of systems biology models using libSBML within Taverna workflows , 2008, Bioinform..
[143] B. Orser,et al. GABAA receptor subtypes underlying general anesthesia , 2008, Pharmacology Biochemistry and Behavior.
[144] Yong-Hae Han,et al. Current industrial practices of assessing permeability and P-glycoprotein interaction , 2006, The AAPS Journal.
[145] Steve Pettifer,et al. Defrosting the Digital Library: Bibliographic Tools for the Next Generation Web , 2008, PLoS Comput. Biol..
[146] D. Noble. The music of life : biology beyond genes , 2008 .
[147] I. Goryanin,et al. Human metabolic network reconstruction and its impact on drug discovery and development. , 2008, Drug discovery today.
[148] J. Szostak,et al. Template-directed synthesis of a genetic polymer in a model protocell , 2008, Nature.
[149] D. Kell,et al. 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries. , 2009, Drug discovery today.